Investor Presentaiton
3 months ended
03/31/2020
6 months ended
06/30/2020
9 months ended
09/30/2020
12 months ended
12/31/2020
3 months ended
03/31/2021
6 months ended
06/30/2021
9 months ended
09/30/2021
4,639 $
16,462 $
21,338 $
7,717 $
(164) $
6,567 $
12,755
Historical Consolidated Statements of Cash Flows (Unaudited)
(in thousands)
Cash flows from operating activities
Net income (loss)
$
Adjustments to reconcile net income (loss) to net cash (used in) provided by operatin
activities:
Depreciation and amortization
Provision for doubtful accounts and sales returns
Stock-based compensation expense
Deferred taxes
21,804
46,088
68,755
92,735
20,461
40,742
60,484
2,488
6,677
10,156
13,230
2,141
4,418
7,992
13,580
33,713
54,556
87,257
30,005
60,554
89,480
954
1,945
1,879
8,837
(1,142)
276
400
Amortization of deferred financing costs and discount
188
376
569
781
506
879
1,234
Other non-cash adjustments
102
477
2,203
2,958
(32)
155
(527)
Changes in operating assets and liabilities, net of acquisition of businesses:
Accounts receivable
(3,876)
(48,167)
(18,319)
(18,414)
10,407
(27,134)
(18,779)
Prepaid expenses and other assets
(5,303)
(7,068)
4,292
22,568
(17,426)
(18,162)
(14,169)
Trade accounts payable
(4,021)
(8,984)
(17,203)
(19,997)
7,550
2,356
10,728
Accrued expenses and other liabilities
(31,694)
(26,520)
(31,595)
(49,232)
549
1,443
2,790
Deferred revenue
(23,364)
22,489
12,534
(485)
(22,752)
27,828
17,400
Net cash (used in) provided by operating activities
(24,503)
37,488
109,165
147,955
30,103
99,922
169,788
Cash flows from investing activities
Purchase of property and equipment
(2,867)
(5,887)
(25,836)
(29,690)
(3,470)
(6,128)
(8,332)
Capitalized software development costs
(10,937)
(21,679)
(32,028)
(42,157)
(9,302)
(19,862)
(29,661)
Net cash used in investing activities
(13,804)
(27,566)
(57,864)
(71,847)
(12,772)
(25,990)
(37,993)
Cash flows from financing activities
Proceeds from issuance of debt
144,700
202,100
267,400
748,500
80,700
128,300
128,300
Payments on debt
(86,075)
(185,250)
(290,999)
(747,563)
(59,667)
(113,477)
(131,272)
Debt issuance costs
Employee taxes paid for withheld shares upon equity award settlement
(19,782)
(20,996)
(593)
(21,286)
(4,586)
(21,425)
(18,426)
(38,712)
(39,012)
Proceeds from exercise of stock options
1
4
4
4
Change in due to customers
Change in customer funds receivable
(311,095)
(733)
(121,612)
(828)
(337,821)
61,214
(353,597)
(170,061)
(386,973)
(4,495)
138
(563)
(5,014)
(5,838)
Purchase of treasury stock
Dividend payments to stockholders
Net cash used in financing activities
(41,001)
(28,066)
(58,074)
(98,353)
(5,960)
(5,960)
(5,960)
(5,960)
(278,944)
(132,542)
(393,750)
(10,679)
(379,619)
(257,038)
(533,148)
Effect of exchange rate on cash, cash equivalents, and restricted cash
Net (decrease) increase in cash, cash equivalents, and restricted cash
Cash, cash equivalents, and restricted cash, beginning of period
Cash, cash equivalents, and restricted cash, end of period
(2,822)
(2,229)
(623)
2,245
(320,073)
(124,849)
(343,072)
67,674
230
(362,058)
992
97
(182,114)
577,295
577,295
577,295
577,295
$
257,222 $
452,446 $
234,223 $
644,969 $
644,969
282,911 $
644,969
(401,256)
644,969
462,855 $
243,713
Note 1: The individual amounts for each quarter may not sum to full year totals due to rounding.
blackbaud
50
50View entire presentation